Patients can expect the following benefits: Decreased appetite Improved blood sugar control Increased fat loss Reduced risk of specific health conditions, such as hypertension and elevated cholesterol levels
Animal studies have shown thyroid C-cell tumours with some GLP-1 receptor agonists, though the relevance to humans is uncertain
Our goal is to ensure patient safety and maximize the benefits of weight loss therapies in conjunction with our surgical and non-surgical services
Its GLP-1 weight-loss program is a newer option, designed for people with a BMI of 30+ (or 27+ with certain health conditions) who may benefit from medications like semaglutide
This includes reduced food preoccupation or food noise, reduced emotional eating, less external eating (i.e., eating that responds to external triggers, irrespective of satiety), and fewer binge eating episodes [52,140]
But what that kind of profile says is that its better to be overweight and strong than it is to be normal weight and weak or unfit
